Government
The ointment had previously been approved for patients ages two and above in 2016.
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
“Using untested drugs without the right evidence could raise false hope and even do more harm than good and cause a shortage of essential drugs that are needed to treat other diseases,” said WHO Director-General Tedros Adhanom Ghebreyesus.
The U.S. Food and Drug Administration issued a Completed Response Letter of Eli Lilly and Company and Boehringer Ingelheim’s Jardiance (empaglifozin) for type 1 diabetes.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
The U.S. Food and Drug Administration has a busy week of possible drug approvals on its calendar. Here’s a look.
“What we have could be a very powerful weapon against these types of viral outbreaks or pandemics because it isn’t pathogen- or virus-specific and could be broadly relevant in these types of situations,” Gil Van Bokkelen, Ph.D., Athersys CEO, told BioSpace.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
The recommended dose of the drug for this age group is based on weight and liver function.
PRESS RELEASES